YMAB Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Y-mAbs Therapeutics Inc

Watchlist Manager

Watchlist

Price: 8.61 USD Market Closed

Market Cap: $391.2m

	Y-mAbs Therapeutics Inc NASDAQ:YMAB	US
H	Hero MotoCorp Ltd NSE:HEROMOTOCO	IN
	US Energy Corp NASDAQ:USEG	US
	Rewalk Robotics Ltd NASDAQ:LFWD	IL
	South32 Ltd F:32ZA	AU

Profitability Summary

Y-mAbs Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

82%

Strong 3Y Average Gross Margin

86%

Declining Gross Margin

90% > 82%

Negative Operating Margin

-31%

Negative 3Y Average Operating Margin

-33%

Operating Margin is Increasing

-93% > -31%

Negative Net Margin

-26%

Negative 3Y Average Net Margin

-30%

Net Margin is Increasing

-98% > -26%

Negative Free Cash Flow Margin

-21%

Negative 3Y Average Free Cash Flow Margin

-26%

Free Cash Flow Margin is Increasing

-85% > -21%

Negative ROE

-24%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-78%

ROIC is Increasing

-252% > -51%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.